Novel trisaccharide based phospholipids as immunomodulators
Srinivasa Reddy Bonam(Indian Institute of Chemical Biology), Sampath Kumar Halmuthur Mahabalarao(Academy of Scientific and Innovative Research), Mallika Alvala(National Institute of Pharmaceutical Education and Research), Debabrata Bhunia(Indian Institute of Chemical Technology), Sridhar Goud Nerella(National Institutes of Health), Sylviane Muller(Centre National de la Recherche Scientifique)
Cited by 14
Related Papers
Lysosomes as a therapeutic target
|Nature Reviews Drug Discovery|2019|751
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
|Immunity|2015|223
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
|Science Translational Medicine|2022|129
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
|Current Medicinal Chemistry|2017|126
PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective
|Frontiers in Medicine|2022|76